Ethane, 1,1,1,2-tetrachloro-
RTECS #
KI8450000
CAS #
Updated
March 2018
Molecular Weight
167.84
Molecular Formula
C2H2Cl4
Synonyms
1,1,1,2-Tetrachloroethane
NCI-C52459
RCRA waste number U208
NCI-C52459
RCRA waste number U208
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg | severe | AMPMAR 35,593,1974 |
skin /rabbit | 500 mg/24H | AMPMAR 35,593,1974 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
gene conversion and mitotic recombination | /Aspergillus nidulans | 250 ppm | MUREAV 201,401,1988 |
mutation in mammalian somatic cells | lymphocyte/mouse | 200 mg/L | EMMUEG 12,85,1988 |
mutation in microorganisms | lymphocyte/mouse | 200 mg/L (+enzymatic activation step) | SCIEAS 236,933,1987 |
mutation in microorganisms | /Salmonella typhimurium | 10 µg/plate (+/-enzymatic activation step) | TECSDY 15,101,1987 |
other mutation test systems | oral/mouse | 1 gm/kg | MUREAV 343,157,1995 |
sex chromosome loss and nondisjunction | /Aspergillus nidulans | 125 ppm | MUREAV 201,401,1988 |
sex chromosome loss and nondisjunction | lung/human | 100 mg/L | MUREAV 369,243,1996 |
sister chromatid exchange | ovary/hamster | 158 mg/L | SCIEAS 236,933,1987 |
specific locus test | ovary/hamster | 0.65 gm/L/24H | MUREAV 602,14,2006 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 128750 mg/kg/103W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors | NTIS** PB83-218206 |
oral/rat | lowest published toxic dose: 128750 mg/kg/103W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | NTIS** PB83-218206 |
oral/rat | lowest published toxic dose: 64375 mg/kg/103W- intermittent | Tumorigenic: Neoplastic by RTECS criteria Skin and Appendages: Tumors | NTIS** PB83-218206 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Mouse, liver | Inhibitor Concentration (50 percent kill): 0.7 mmol/L/2H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 3,145,1989 |
In Vitro/Rat, liver | Inhibitor Concentration (50 percent kill): 1.4 mmol/L/2H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 3,145,1989 |
inhalation/rabbit | lowest published toxic concentration: 2000 ppm | Lung, Thorax, or Respiration: Acute pulmonary edema Lung, Thorax, or Respiration: Cough | VCVGH* -,384,1990 |
inhalation/rabbit | lowest published toxic concentration: 2500 ppm | Lung, Thorax, or Respiration: Acute pulmonary edema Liver: Hepatitis (hepatocellular necrosis), zonal Blood: Hemorrhage | VCVGH* -,384,1990 |
inhalation/rabbit | lethal concentration (50 percent kill): 2800 ppm/4H | Gastrointestinal: Hypermotility, diarrhea | AMPMAR 35,593,1974 |
inhalation/rabbit | lethal concentration (50 percent kill): 2800 mg/m3/4H | VCVGH* -,383,1990 | |
inhalation/rat | lethal concentration (50 percent kill): 2100 mg/m3/4H | VCVGH* -,383,1990 | |
inhalation/rat | lethal concentration (50 percent kill): 2100 ppm/4H | Gastrointestinal: Hypermotility, diarrhea | AMPMAR 35,593,1974 |
inhalation/rat | lowest published toxic concentration: 2000 ppm | Lung, Thorax, or Respiration: Cough | VCVGH* -,384,1990 |
inhalation/rat | lowest published toxic concentration: 3000 ppm | Lung, Thorax, or Respiration: Acute pulmonary edema | VCVGH* -,384,1990 |
inhalation/rat | lowest published toxic concentration: 4000 ppm | Lung, Thorax, or Respiration: Acute pulmonary edema Liver: Other changes | VCVGH* -,384,1990 |
intraperitoneal/mouse | lethal dose (50 percent kill): 1275 mg/kg | SAIGBL 8,371,1966 | |
oral/guinea pig | lowest published toxic dose: 600 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal | VCVGH* -,384,1990 |
oral/mouse | lowest published toxic dose: 1000 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal | VCVGH* -,384,1990 |
oral/mouse | lethal dose (50 percent kill): 1500 mg/kg | VCVGH* -,383,1990 | |
oral/rat | lethal dose (50 percent kill): 670 mg/kg | VCVGH* -,383,1990 | |
skin/rabbit | lethal dose (50 percent kill): 20 mg/kg | VCVGH* -,383,1990 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | lowest published toxic dose: 16 gm/kg/40D- intermittent | Behavioral: Sleep | SAIGBL 8,371,1966 |
intraperitoneal/mouse | lowest published toxic dose: 2400 mg/kg/3D- intermittent | Behavioral: Sleep Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | SAIGBL 8,371,1966 |
oral/mouse | lowest published toxic dose: 14 gm/kg/14D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-237,1982 |
oral/mouse | lowest published toxic dose: 32500 mg/kg/13W- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-237,1982 |
oral/rat | lowest published toxic dose: 128750 mg/kg/103W- intermittent | Brain and Coverings: Tumors Tumorigenic: Active as anti-cancer agent | NTIS** PB83-218206 |
oral/rat | lowest published toxic dose: 7 gm/kg/14D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-237,1982 |
Reviews
Organization | Standard | Reference |
---|---|---|
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 41,87,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 71,1133,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 106,487,2014 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human No Adequate Data | IMEMDT 41,87,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human No Adequate Data | IMEMDT 71,1133,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 106,487,2014 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMEMDT 71,1133,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 2B | IMEMDT 106,487,2014 |
TOXICOLOGY REVIEW | AIHAAP 40(3),A46,1979 | |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | MUTAEX 14,5,1999 | |
TOXICOLOGY REVIEW | MUREAV 628,67,2007 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | MUREAV 769,34,2014 | |
TOXICOLOGY REVIEW | MUREAV 802,1,2016 | |
TOXICOLOGY REVIEW | MUTAEX 31,347,2016 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO 1,1,1,2-TETRACHLOROETHANE-air | Handle with caution | NIOSH* DHHS #92-100,1992 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health